Harvard Bioscience Inc. (HBIO) vs its competitors

Harvard Bioscience Inc. against medical instruments and supplies

Harvard Bioscience Inc. is the 43rd largest of 48 graded companies. Showing 5 of them, including HBIO itself. 2 more are in this industry but have no grade yet, so they are left out rather than shown blank.

Company	Grade	Market value	Revenue	Profit margin	Free cash flow	Price to earnings
Intuitive Surgical, Inc.ISRG	A+	$145.6B	$11B	28.4%	$3.2B	47.27
Becton, Dickinson And CompanyBDX	B	$49.6B	$23.3B	4.0%	$2.6B	54.82
ResMed Inc.RMD	B+	$32.2B	$5.7B	26.9%	$1.6B	21.37
Alcon Inc.ALC	B	$31.9B	$9.5B	10.3%	$1.7B	33.05
Harvard Bioscience, Inc.HBIO	F-	$36.5M	$87.8M	-11.9%	-$1.1M	—

43 more medical instruments and supplies companies

Graded on the same five checks, from their own SEC filings.

A blank price-to-earnings means a loss, not a missing figure — the ratio has no meaning when there are no earnings to divide by, and printing a negative one would make the least profitable company look the cheapest.

Grades are trailing twelve months from each company’s own SEC filings, so they move only when a company files. Every column is computed by the same code that graded Harvard Bioscience Inc. on the overview — nothing here comes from a data vendor’s own ratios.

Industry membership is not a judgement about how similar two businesses are. It groups companies by what they are classified as, which is a starting point for comparison rather than a claim that they compete.